HAVCR2 and neoplasm: Whether VISTA, CTLA-4, TIM-3, and other immune regulators suppresses CD8+ T cell cytotoxic killing in our system is unknown but represents a promising avenue for future research that could explain why PD-1/PD-L1 interactions do not suppress tumor CD8+ T cell killing in our system.